Primary group A streptococcal peritonitis in a previously healthy child

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 11, 2002, Pages 847-848

  Gillespie, Robert S ^a   Hauger, Sarmistha B ^b   Holt, Richard M ^b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b Children's Hospital of Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; GENTAMICIN; IMMUNOGLOBULIN; PENICILLIN G;

ABDOMINAL PAIN; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LAPAROTOMY; NONHUMAN; PERITONITIS; PRESCHOOL CHILD; STREPTOCOCCUS GROUP A;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CLINDAMYCIN; FEMALE; GENTAMICINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PENICILLINS; PERITONITIS; STREPTOCOCCUS;

EID: 0036965658     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000026944     Document Type: Article

References (9)

1. Freij BJ, Votteler TP, McCracken Jr GH. Primary peritonitis in previously healthy children. Am J Dis Child 1984; 138: 1058-61.
2. McDougal WS, Izant Jr RJ, Zollinger Jr RM. Primary peritonitis in infancy and childhood. Ann Surg 1975; 181: 310-3.
3. Givner LB. Invasive disease due to group A beta-hemolytic streptococci: continued occurrence in children in North Carolina. South Med J 1998; 91: 333-7.
4. Givner LB, Abramson JS, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991; 118: 341-6.
5. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105: E60.
6. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 1996; 156: 3057-64.
7. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1998; 158: 23-8.
8. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J 1999; 18: 1069-72.
9. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999; 28: 800-7.